Category: Pharmaceuticals
Global Pharmaceuticals
-
Tuberculosis Testing
... at a CAGR of 5.1% over the analysis period 2023-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$714.5 Million by the end of ... Read More
-
Anticoagulants
... of 9.1% over the analysis period 2023-2030. NOACs Drug Class, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis ... Read More
-
Nanocatalysts
... of 7.5% over the analysis period 2023-2030. Refinery & Petrochemicals Application, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$1.9 Billion by the end of the ... Read More
-
Ovulation Test
... at a CAGR of 4.0% over the analysis period 2023-2030. Urine Test, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.2 Billion by the end of ... Read More
-
Global Gait Analyzer Market Research Report 2024
... during the forecast period 2024-2030. In 2023 the Global Gait Analyzer production were 1,057 Units and it will be 1,908 Units in 2030, with a CAGR of 8.62% between 2024 and 2030. Europe and North ... Read More
-
Radio Frequency Identification (RFID) Technology
... is expected to reach US$97.5 Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2023-2030. RFID Tags, one of the segments analyzed in the report, is expected to record a 16.1% ... Read More
-
Contract Research Outsourcing
... by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Clinical Research Services, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$61.2 Billion ... Read More
-
Orthopedic Braces & Support, Casting and Splints
... US$6.5 Billion in the year 2023, is expected to reach US$10.1 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Orthopedic Braces & Supports, one of the segments analyzed in ... Read More
-
Herpes Simplex Virus Infections
... reach US$6.6 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 6.6% CAGR The Herpes ... Read More
-
Automated Storage and Retrieval Systems (ASRS)
... the year 2023, is expected to reach US$13.4 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Unit Load ASRS, one of the segments analyzed in the report, is expected ... Read More
-
Corporate Wellness
... at a CAGR of 6.6% over the analysis period 2023-2030. Small-scale Organizations End-Use, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$19.2 Billion by the end ... Read More
-
Interventional Radiology Systems
... by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. MRI Systems, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$12.7 Billion by ... Read More
-
Bulk Paclitaxel
... at a CAGR of 8.6% over the analysis period 2023-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$139.1 Million by the end ... Read More
-
Cardiovascular Drugs
... at a CAGR of 3.5% over the analysis period 2023-2030. Anticoagulants, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$57.7 Billion by the end of the ... Read More
-
Lung Cancer Therapeutics
... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach ... Read More
-
Organic Foods and Beverages
... reach US$681.4 Billion by 2030, growing at a CAGR of 14.1% over the analysis period 2023-2030. Organic Fruits & Vegetables, one of the segments analyzed in the report, is expected to record a 15.3% CAGR ... Read More
-
Rheumatoid Arthritis Therapeutics
... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Pharmaceuticals Molecule, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$28.0 Billion by ... Read More
-
Breast Cancer Therapeutics
... by 2030, growing at a CAGR of 12.3% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$74.9 Billion by ... Read More
-
Cosmetic Procedures and Products
... reach US$60.0 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Facial Injectable, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach ... Read More
-
Condoms
... of 5.8% over the analysis period 2023-2030. Natural Condoms, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.2 Billion by the end of the analysis period. ... Read More
-
Branded Apparel
... at a CAGR of 2.4% over the analysis period 2023-2030. Men`s Branded Apparel, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$203.3 Billion by the end ... Read More
-
Prostate Cancer Therapeutics
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$21.0 Billion by ... Read More
-
3D Dental Scanners
... by 2030, growing at a CAGR of 10.2% over the analysis period 2023-2030. Desktop / Laboratory Scanners, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$1.2 ... Read More
-
Ablation Technologies
... at a CAGR of 9.8% over the analysis period 2023-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$3.7 Billion by the end of ... Read More
-
Continuous Renal Replacement Therapy (CRRT)
... is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Dialysates & Replacement Fluids, one of the segments analyzed in the report, is expected to record ... Read More
Research Assistance
